ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,537 | -74.2% | 110,297 | 0.0% | 0.00% | – |
| Q2 2023 | $56,251 | +4.4% | 110,297 | +32.9% | 0.00% | – |
| Q4 2022 | $53,859 | -62.3% | 82,975 | 0.0% | 0.00% | – |
| Q3 2022 | $143,000 | +38.8% | 82,975 | 0.0% | 0.00% | – |
| Q2 2022 | $103,000 | -70.8% | 82,975 | -84.6% | 0.00% | – |
| Q1 2022 | $353,000 | -40.2% | 540,542 | 0.0% | 0.00% | – |
| Q4 2021 | $590,000 | -38.0% | 540,542 | +3.4% | 0.00% | – |
| Q3 2021 | $952,000 | -75.6% | 522,983 | -64.6% | 0.00% | -100.0% |
| Q2 2021 | $3,904,000 | -26.2% | 1,478,785 | +0.7% | 0.00% | -50.0% |
| Q1 2021 | $5,288,000 | +47.8% | 1,468,765 | +3.5% | 0.00% | +100.0% |
| Q4 2020 | $3,577,000 | +2.0% | 1,419,101 | +1.9% | 0.00% | -50.0% |
| Q3 2020 | $3,508,000 | -19.6% | 1,392,013 | +4.7% | 0.00% | 0.0% |
| Q2 2020 | $4,361,000 | +51.3% | 1,329,337 | +13.0% | 0.00% | 0.0% |
| Q1 2020 | $2,883,000 | -39.0% | 1,176,653 | +17.6% | 0.00% | -33.3% |
| Q4 2019 | $4,723,000 | +12.9% | 1,000,527 | +2.4% | 0.00% | +50.0% |
| Q3 2019 | $4,182,000 | -20.2% | 976,974 | +8.7% | 0.00% | -33.3% |
| Q2 2019 | $5,239,000 | +63.0% | 898,615 | +7.6% | 0.00% | +50.0% |
| Q1 2019 | $3,215,000 | +131.0% | 834,853 | +12.2% | 0.00% | +100.0% |
| Q4 2018 | $1,392,000 | -35.9% | 743,958 | +9.7% | 0.00% | 0.0% |
| Q3 2018 | $2,171,000 | +0.7% | 678,307 | -5.0% | 0.00% | -50.0% |
| Q2 2018 | $2,156,000 | -17.2% | 713,837 | +7.5% | 0.00% | 0.0% |
| Q1 2018 | $2,604,000 | -2.4% | 664,222 | +3.0% | 0.00% | 0.0% |
| Q4 2017 | $2,669,000 | -29.7% | 644,642 | +4.2% | 0.00% | -33.3% |
| Q3 2017 | $3,799,000 | +5.3% | 618,589 | +6.6% | 0.00% | 0.0% |
| Q2 2017 | $3,609,000 | +5.7% | 580,149 | +7.8% | 0.00% | 0.0% |
| Q1 2017 | $3,413,000 | +25.0% | 538,289 | +5.5% | 0.00% | 0.0% |
| Q4 2016 | $2,731,000 | -1.7% | 510,383 | +3.5% | 0.00% | 0.0% |
| Q3 2016 | $2,777,000 | +8.0% | 493,146 | +5.3% | 0.00% | 0.0% |
| Q2 2016 | $2,572,000 | -24.4% | 468,322 | +2.1% | 0.00% | -25.0% |
| Q1 2016 | $3,404,000 | -4.6% | 458,650 | +6.8% | 0.00% | -20.0% |
| Q4 2015 | $3,568,000 | -2.1% | 429,259 | +6.2% | 0.01% | 0.0% |
| Q3 2015 | $3,644,000 | -26.7% | 404,375 | -2.3% | 0.01% | -28.6% |
| Q2 2015 | $4,968,000 | +28.4% | 413,926 | +15.3% | 0.01% | +40.0% |
| Q1 2015 | $3,868,000 | +109.8% | 359,059 | -1.3% | 0.01% | +66.7% |
| Q4 2014 | $1,844,000 | +62.5% | 363,689 | -15.4% | 0.00% | +50.0% |
| Q3 2014 | $1,135,000 | -24.4% | 429,737 | +15.4% | 0.00% | -33.3% |
| Q2 2014 | $1,501,000 | +25.2% | 372,247 | +42.3% | 0.00% | +50.0% |
| Q1 2014 | $1,199,000 | +37.8% | 261,607 | +30.6% | 0.00% | 0.0% |
| Q4 2013 | $870,000 | +24.1% | 200,273 | +20.1% | 0.00% | +100.0% |
| Q3 2013 | $701,000 | +96.4% | 166,725 | -1.2% | 0.00% | 0.0% |
| Q2 2013 | $357,000 | – | 168,731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |